Lyell Immunopharma, Inc.
LYEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $105,597 | $145,647 | $123,554 | $293,828 |
| Short-Term Investments | $264,930 | $400,576 | $516,598 | $320,966 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9,067 | $8,463 | $11,143 | $11,492 |
| Total Curr. Assets | $379,594 | $554,686 | $651,295 | $626,286 |
| Property Plant & Equip (Net) | $72,939 | $142,317 | $166,265 | $166,639 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $32,014 | $48,507 | $115,041 | $330,532 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6,312 | $4,519 | $4,960 | $3,949 |
| Total NC Assets | $111,265 | $195,343 | $286,266 | $501,120 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $490,859 | $750,029 | $937,561 | $1,127,406 |
| Liabilities | – | – | – | – |
| Payables | $5,366 | $4,817 | $3,917 | $3,207 |
| Short-Term Debt | $7,974 | $6,273 | $4,534 | $1,169 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $4,988 |
| Other Curr. Liab. | $40,448 | $23,429 | $28,577 | $37,374 |
| Total Curr. Liab. | $53,788 | $34,519 | $37,028 | $46,738 |
| LT Debt | $50,994 | $56,894 | $63,168 | $66,650 |
| Deferred Rev, NC | $0 | $0 | $0 | $79,665 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3,253 | $3,664 | $4,113 | $4,566 |
| Total NC Liab. | $54,247 | $60,558 | $67,281 | $150,881 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $58,968 | $63,167 | $67,702 | $67,819 |
| Total Liabilities | $108,035 | $95,077 | $104,309 | $197,619 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $29 | $25 | $25 | $24 |
| Retained Earnings | -$1,345,106 | -$1,002,112 | -$767,480 | -$584,362 |
| AOCI | $291 | -$94 | -$7,599 | -$1,623 |
| Other Equity | $1,727,610 | $1,657,133 | $1,608,306 | $1,515,748 |
| Total Equity | $382,824 | $654,952 | $833,252 | $929,787 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $490,859 | $750,029 | $937,561 | $1,127,406 |
| Net Debt | -$46,629 | -$82,480 | -$55,852 | -$226,009 |